FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...